A sandwich ELISA for the quantification of the anticancer peptide CIGB-552 in human plasma

被引:0
作者
Hernandez, Nivaldo Angel Gomez [1 ]
Perez, Gilda Lemos [2 ]
Arteaga, Amalia Vazquez [2 ]
Perez, Hilda Elisa Garay [3 ]
Arguellez, Brizaida Oliva [1 ]
Rico, Ania Cabrales [2 ]
Guardia, Airela Llamo [4 ]
Masso, Julio Raul Fernandez [1 ]
机构
[1] Ctr Genet Engn & Biotechnol, Pharmaceut Dept, Havana, Cuba
[2] Ctr Genet Engn & Biotechnol, Chem Phys Dept, Havana, Cuba
[3] Ctr Genet Engn & Biotechnol, Peptide Synth Dept, Havana, Cuba
[4] Ctr Genet Engn & Biotechnol, Monoclonal Antibody Prod Dept, Havana, Cuba
关键词
Cancer; CIGB-552; peptide; Antibodies; ELISA; Validation;
D O I
10.1016/j.ab.2024.115725
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
CIGB-552 is a synthetic anticancer peptide that has been evaluated in vitro and in vivo in lung and colon cancer models. To optimize therapy in the clinic, pharmacokinetic studies are necessary. Previously, a sandwich-type enzyme-linked immunosorbent assay (ELISA) had been developed by our working group for the quantification of CIGB-552 in biological matrices. The objective of this work was to carry out the full validation of the ELISA to support its application in clinical trials. First, we obtained a polyclonal antibody specific for CIGB-552 and with purity greater than 95 %. The lower limit of quantification and the upper limit of quantification were 3125 ng/ml and 200 ng/ml, respectively. The method is exact and precise in the quantification of the peptide with relative error and coefficient of variation values less than 20 %. The ELISA is specific in the presence of CIGB-552 metabolites in the sample, and also presents robustness to certain protocol variations. In summary, the validated ELISA meets the requirements for its application in upcoming clinical trials as part of pharmacokinetic studies.
引用
收藏
页数:10
相关论文
共 29 条
  • [21] Development and evaluation of a direct sandwich enzyme-linked immunosorbent assay for the quantification of lipoprotein lipase mass in human plasma
    Kimura, H
    Ohkaru, Y
    Katoh, K
    Ishii, H
    Sunahara, N
    Takagi, A
    Ikeda, Y
    CLINICAL BIOCHEMISTRY, 1999, 32 (01) : 15 - 23
  • [22] A Sensitive and Cost-Effective Chemiluminescence ELISA for Measurement of Amyloid-β 1-42 Peptide in Human Plasma
    Mehta, Pankaj D.
    Patrick, Bruce A.
    Miller, David L.
    Coyle, Patricia K.
    Wisniewski, Thomas
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 78 (03) : 1237 - 1244
  • [23] PRODUCTION OF MONOCLONAL-ANTIBODIES AGAINST THE HUMAN ANAPHYLATOXIN-C5A DES ARG AND THEIR APPLICATION IN THE NEOEPITOPE-SPECIFIC SANDWICH-ELISA FOR THE QUANTIFICATION OF C5A DES ARG IN PLASMA
    BERGH, K
    IVERSEN, OJ
    JOURNAL OF IMMUNOLOGICAL METHODS, 1992, 152 (01) : 79 - 87
  • [24] Simultaneous quantification of rituximab and eculizumab in human plasma by liquid chromatography-tandem mass spectrometry and comparison with rituximab ELISA kits
    Truffot, Aurelie
    Jourdil, Jean-Francois
    Seitz-Polski, Barbara
    Malvezzi, Paolo
    Brglez, Vesna
    Stanke-Labesque, Francoise
    Gautier-Veyret, Elodie
    CLINICAL BIOCHEMISTRY, 2021, 87 : 60 - 66
  • [25] An Optimised Indirect ELISA Protocol for Detection and Quantification of Anti-viral Antibodies in Human Plasma or Serum: A Case Study Using SARS-CoV-2
    Baine, Claire
    Sembera, Jackson
    Oluka, Gerald Kevin
    Katende, Joseph Ssebwana
    Ankunda, Violet
    Serwanga, Jennifer
    BIO-PROTOCOL, 2023, 13 (24):
  • [26] A simple and efficient sequential electrokinetic and hydrodynamic injections in micellar electrokinetic chromatography method for quantification of anticancer drug 5-fluorouracil and its metabolite in human plasma
    Semail, Nadhiratul-Farihin
    Noordin, Siti Salmah
    Keyon, Aemi Syazwani Abdul
    Waras, Maisarah Nasution
    Saad, Bahruddin
    Kamaruzaman, Sazlinda
    Mohamad Zain, Nur Nadhirah
    Azizi, Juzaili
    Aziz, Mohd Yusmaidie
    Yahaya, Noorfatimah
    BIOMEDICAL CHROMATOGRAPHY, 2021, 35 (05)
  • [27] Simultaneous quantification of infliximab and adalimumab in human plasma by liquid chromatography-tandem mass spectrometry using ready-to-use kit and comparison with two ELISA methods
    Tron, C.
    Lemaitre, F.
    Bros, P.
    Goulvestre, C.
    Franck, B.
    Mouton, N.
    Bagnos, S.
    Coriat, R.
    Bellissant, E.
    Khoudour, N.
    Lebert, D.
    Blanchet, B.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2022, 36 : 110 - 110
  • [28] Comparison of a stable isotope labeled (SIL) peptide and an extended SIL peptide as internal standards to track digestion variability of an unstable signature peptide during quantification of a cancer biomarker, human osteopontin, from plasma using capillary microflow LC-MS/MS
    Faria, Morse
    Halquist, Matthew S.
    Yuan, Moucun
    Mylott, William, Jr.
    Jenkins, Rand G.
    Karnes, H. Thomas
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2015, 1001 : 156 - 168
  • [29] Immunoaffinity Purification Using Anti-PEG Antibody Followed by Two-Dimensional Liquid Chromatography/Tandem Mass Spectrometry for the Quantification of a PEGylated Therapeutic Peptide in Human Plasma
    Xu, Yang
    Mehl, John T.
    Bakhtiar, Ray
    Woolf, Eric J.
    ANALYTICAL CHEMISTRY, 2010, 82 (16) : 6877 - 6886